| Full Name | Jon S Heist Do Pa |
|---|---|
| Speciality | Family Medicine |
| Location | 361 N Main St, Glassboro, New Jersey |
| Authorized Official Name and Position | Jen S Heist (PRESIDENT PHYSICIAN) |
| Authorized Official Contact | 8568818618 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jon S Heist Do Pa 361 N Main St Glassboro NJ 08028 Ph: (856) 881-8618 | Jon S Heist Do Pa 361 N Main St Glassboro NJ 08028 Ph: (856) 881-8618 |
| NPI Number | 1467467175 |
|---|---|
| Provider Enumeration Date | 07/30/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 2961472618 |
|---|---|
| Medicare Enrollment ID | O20040729000529 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
Researchers in China have reported the successful design and synthesis of two antiviral compounds that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s main protease, essential in virus replication.
Men will have to brush up on caring for their teeth and gums to equal the oral hygiene efforts of women, according to survey findings from the American Dental Association (ADA).
Many primary care pediatricians say they feel uncomfortable providing health care to patients with genetic disorders. Also, many do not consistently discuss all risks and benefits of genetic tests with patients, according to research published today in the American Journal of Medical Genetics.
Endo Pharmaceuticals announced today that it is terminating its research program and collaboration related to the development of axomadol.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467467175 | NPI | - | NPPES |
| 8091609 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Jon S Heist |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1760501373 PECOS PAC ID: 6002802899 Enrollment ID: I20040426000784 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
Researchers in China have reported the successful design and synthesis of two antiviral compounds that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s main protease, essential in virus replication.
Men will have to brush up on caring for their teeth and gums to equal the oral hygiene efforts of women, according to survey findings from the American Dental Association (ADA).
Many primary care pediatricians say they feel uncomfortable providing health care to patients with genetic disorders. Also, many do not consistently discuss all risks and benefits of genetic tests with patients, according to research published today in the American Journal of Medical Genetics.
Endo Pharmaceuticals announced today that it is terminating its research program and collaboration related to the development of axomadol.
› Verified 6 days ago
| Provider Name | Heather C Wilmore |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194123133 PECOS PAC ID: 4981920626 Enrollment ID: I20150224001112 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
Researchers in China have reported the successful design and synthesis of two antiviral compounds that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s main protease, essential in virus replication.
Men will have to brush up on caring for their teeth and gums to equal the oral hygiene efforts of women, according to survey findings from the American Dental Association (ADA).
Many primary care pediatricians say they feel uncomfortable providing health care to patients with genetic disorders. Also, many do not consistently discuss all risks and benefits of genetic tests with patients, according to research published today in the American Journal of Medical Genetics.
Endo Pharmaceuticals announced today that it is terminating its research program and collaboration related to the development of axomadol.
› Verified 6 days ago
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
Researchers in China have reported the successful design and synthesis of two antiviral compounds that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s main protease, essential in virus replication.
Men will have to brush up on caring for their teeth and gums to equal the oral hygiene efforts of women, according to survey findings from the American Dental Association (ADA).
Many primary care pediatricians say they feel uncomfortable providing health care to patients with genetic disorders. Also, many do not consistently discuss all risks and benefits of genetic tests with patients, according to research published today in the American Journal of Medical Genetics.
Endo Pharmaceuticals announced today that it is terminating its research program and collaboration related to the development of axomadol.
› Verified 6 days ago
Rowan Wellness Center - Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 Mullica Hill Rd, Winans Hall, Glassboro, NJ 08028 Phone: 856-256-4333 Fax: 856-256-4427 | |
Inspira Health Network Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1120 Delsea Dr N, Glassboro, NJ 08028 Phone: 856-205-7071 | |
Underwood-memorial Hospital Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1120 Delsea Dr N, Glassboro, NJ 08028 Phone: 856-582-0500 Fax: 856-582-0163 | |
Completecare Health Network Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 715 Delsea Dr N, Units 3, 4, & 5, Glassboro, NJ 08028 Phone: 856-451-4700 Fax: 856-575-0818 | |
American Workcare, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1125 North Delsea Dr, Glassboro, NJ 08028 Phone: 856-218-7600 Fax: 856-218-7800 | |
Kennedy Health Alliance Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 N Main St, Glassboro, NJ 08028 Phone: 844-542-2273 |